Quantcast
Last updated on April 23, 2014 at 20:10 EDT

Latest Genetics Stories

2014-02-24 23:23:18

The global market for DNA sequencing products and services was valued at $3.5 billion in 2012 and was estimated at nearly $4.5 billion for 2013. BCC Research expects the market to grow to nearly $11.7 billion by 2018, and register a five-year compound annual growth rate of 21.2% from 2013 to 2018. Wellesley, Mass. (PRWEB) February 24, 2014 According to a new technical market research report DNA Sequencing: Emerging Technologies and Applications, from BCC Research...

2014-02-24 23:20:43

New research report “Cystic Fibrosis Therapeutics in Major Developed Markets to 2019 - CFTR Modulators Initiate Drive towards Personalized Treatment and Market Growth” worked out by GBI Research is now available at MarketPublishers.com. According to the study, the combined value of the cystic fibrosis (CF) markets in the top 8 developed economies is set to grow at a 30.4% CAGR through 2019. London, UK (PRWEB) February 24, 2014 In 2012, the combined value of the cystic fibrosis (CF)...

2014-02-24 12:27:26

SAN DIEGO, Feb. 24, 2014 /PRNewswire/ -- Arcturus Therapeutics, Inc., a leading RNA medicines company pursuing rare diseases, today announced it will present at BIOCOM's Global Life Science Partnering Conference being held on February 26 and 27, 2014 at the Lodge in Torrey Pines, La Jolla, California. In addition to providing an update on its flagship program targeting transthyretin (TTR)-mediated amyloidosis, Arcturus will present data for its proprietary LUNAR(TM) delivery...

2014-02-24 08:28:42

DUBLIN, February 24, 2014 /PRNewswire/ -- (http://www.researchandmarkets.com/research/zppfx2/transcriptomics) have announced the addition of the "Concise Analysis on the International Transcriptomics Technologies Market - Forecast to 2019" [http://www.researchandmarkets.com/research/zppfx2/transcriptomics ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Transcriptomics is one of the flourishing Omics technologies...

2014-02-24 08:27:38

WESTBOROUGH, Mass., Feb. 24, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President & CEO, Dr. Geert Cauwenbergh, will present at the 24(th) Annual Wall Street Analyst Forum on Monday, March 3, 2014 at 12:50pm EST. Dr. Cauwenbergh will discuss the...

Taxonomy Boris Vinatzer
2014-02-24 04:45:12

redOrbit Staff & Wire Reports - Your Universe Online A new naming system proposed by one Virginia Tech scientist proposes moving beyond the current biological naming system and supplementing it with a new classification method based on an organism’s genome sequence. The new method was developed by Boris Vinatzer, an associate professor in the College of Agriculture and Life Science's Department of Plant Pathology, Physiology, and Weed Science, and he believes that it will create a...

2014-02-21 23:20:43

RnRMarketResearch.com adds “Gene Expression Analysis Market – by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] – Global Forecast To 2018” to its store. Dallas, Texas (PRWEB) February 21, 2014 Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological...

2014-02-21 16:23:09

On track to initiate Phase 3 study in infants with SMA in the middle of this year CARLSBAD, Calif., Feb. 21, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMN(Rx) in infants with spinal muscular atrophy (SMA). To date, all four infants in the 6 mg cohort have been in the study for over six months and are now approximately nine and a half to 16 months in age with an average age...

2014-02-21 08:25:03

Average increase of 3.7 points observed in muscle function score in SMA children treated with 9 mg of ISIS-SMN Rx CARLSBAD, Calif., Feb. 21, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) today announced top-line results from an ongoing open-label, multiple-dose study of ISIS-SMN(Rx )in children with spinal muscular atrophy (SMA). In this study, ISIS-SMN(Rx) was well tolerated at all dose levels in children with SMA. Consistent with single-dose observations,...

Gene Variants Affect Blood Pressure
2014-02-21 04:53:42

redOrbit Staff & Wire Reports - Your Universe Online An international team of researchers has identified 11 new DNA sequence variants associated with blood pressure levels and heart disease, 10 of which could be are in or near genes encoding proteins and appear to be likely targets for drugs that are currently available or in development. The study, which appears in Thursday’s edition of the American Journal of Human Genetics, examined the DNA of 87,736 individuals in order to...


Latest Genetics Reference Libraries

GloFish
2013-10-03 10:12:03

The GloFish is a patented and trademarked brand of genetically modified fluorescent fish. Various GloFish are currently on the market. Zebrafish were the first GloFish that were available within pet stores and are now sold in bright green, red, orange-yellow, blue, and purple fluorescent colors. Recently, Electric Green, Sunburst Orange, and Moonrise Pink colored tetra (Gymnocorymbus ternetzi) and Electric Green tiger barb (Puntius tetrazona) have been incorporated to the lineup. Although not...

Knockout Mouse
2013-10-02 11:52:01

A Knockout Mouse is a genetically engineered mouse in which researchers have inactivated, or “knocked out,” an existing gene by replacing it or disrupting it with an artificial piece of DNA. The loss of gene activity frequently causes changes in a mouse’s phenotype, which includes appearance, behavior, or other apparent and biochemical characteristics. Knockout mice are significant animal models for studying the role of genes which have been sequenced but whose functions haven’t...

Blue Rose
2013-10-02 08:33:40

A Blue Rose is a flower of the genus Rosa belonging to the family Rosaceae that presents blue to violet pigmentation instead of the more common white, red, or yellow coloration. Blue roses are frequently portrayed in literature and art as a symbol of love and prosperity to those who seek it, but don’t exist in nature as a result of genetic limitations. In 2004, researchers utilized genetic modification to produce roses that contain the blue pigment delphinidin. After 13 years of...

Brief Introduction To DNA Probes
2014-01-12 00:00:00

DNA probes help scientists to detect a specific gene in a long DNA sequence. According to Dr. Michael A. Pfaller, DNA probes are “single-stranded pieces of nucleic acid, labeled with a specific tracer (isotope, enzyme, or chromophore), that will hydrogen bond (hybridize) with complementary single-stranded pieces of DNA (or RNA) under the appropriate conditions of pH, temperature, and iconic strength.” The Foundation for Genomics and Population Health website has a helpful video about...

Caenorhabditis elegans
2014-01-12 00:00:00

Caenorhabditis elegans is a species of parasitic roundworm in the Nematoda phylum. It can be found in temperate regions, in many different areas of the world. It prefers to reside in nutrient rich soils. Its scientific name is derived from the Greek terms Caeno, meaning recent, rhabditis, meaning rod-like, and the Latin term elegans, which means elegant. It was first named by Maupas in 1900, but was not classified in the Caenorhabditis subgenus until 1952 by Osche. Caenorhabditis elegans...

More Articles (1286 articles) »